These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1067 related articles for article (PubMed ID: 16518376)

  • 1. Adenosine receptors as therapeutic targets.
    Jacobson KA; Gao ZG
    Nat Rev Drug Discov; 2006 Mar; 5(3):247-64. PubMed ID: 16518376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs.
    Akkari R; Burbiel JC; Hockemeyer J; Müller CE
    Curr Top Med Chem; 2006; 6(13):1375-99. PubMed ID: 16918456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.
    Jacobson KA; IJzerman AP; Müller CE
    Biochem Pharmacol; 2021 May; 187():114311. PubMed ID: 33130128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal chemistry of adenosine A1 receptor ligands.
    Soudijn W; van Wijngaarden I; IJzerman AP
    Curr Top Med Chem; 2003; 3(4):355-67. PubMed ID: 12570755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine receptors and their modulators.
    Müller CE; Scior T
    Pharm Acta Helv; 1993 Sep; 68(2):77-111. PubMed ID: 8234392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal chemistry of adenosine A3 receptor ligands.
    Müller CE
    Curr Top Med Chem; 2003; 3(4):445-62. PubMed ID: 12570761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to adenosine receptors as therapeutic targets.
    Jacobson KA
    Handb Exp Pharmacol; 2009; (193):1-24. PubMed ID: 19639277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine and ischemic preconditioning.
    Liang BT; Jacobson KA
    Curr Pharm Des; 1999 Dec; 5(12):1029-41. PubMed ID: 10607860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of purinergic signaling in cardiovascular diseases.
    Ralevic V; Burnstock G
    Drug News Perspect; 2003 Apr; 16(3):133-40. PubMed ID: 12819811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A1 adenosine receptors and their ligands: overview and recent developments.
    Müller CE
    Farmaco; 2001; 56(1-2):77-80. PubMed ID: 11347971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicinal chemistry of adenosine, P2Y and P2X receptors.
    Jacobson KA; Müller CE
    Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in adenosine receptor ligands and their potential as novel drugs.
    Müller CE; Jacobson KA
    Biochim Biophys Acta; 2011 May; 1808(5):1290-308. PubMed ID: 21185259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future.
    Borah P; Deka S; Mailavaram RP; Deb PK
    Curr Pharm Des; 2019; 25(26):2792-2807. PubMed ID: 31333097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal chemistry and pharmacology of A2B adenosine receptors.
    Volpini R; Costanzi S; Vittori S; Cristalli G; Klotz KN
    Curr Top Med Chem; 2003; 3(4):427-43. PubMed ID: 12570760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
    Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
    Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.
    Fredholm BB; IJzerman AP; Jacobson KA; Linden J; Müller CE
    Pharmacol Rev; 2011 Mar; 63(1):1-34. PubMed ID: 21303899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation.
    Polosa R; Holgate ST
    Curr Drug Targets; 2006 Jun; 7(6):699-706. PubMed ID: 16787172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.
    Link AA; Kino T; Worth JA; McGuire JL; Crane ML; Chrousos GP; Wilder RL; Elenkov IJ
    J Immunol; 2000 Jan; 164(1):436-42. PubMed ID: 10605040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives.
    Deb PK; Deka S; Borah P; Abed SN; Klotz KN
    Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine receptor ligands-recent developments part I. Agonists.
    Muller CE
    Curr Med Chem; 2000 Dec; 7(12):1269-88. PubMed ID: 11032971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.